A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

NCT01386489 ·Status: COMPLETED ·Phase: PHASE1

A Study of 1592U89 in HIV-Infected Adults

NCT00002200 ·Status: COMPLETED ·Phase: NA

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

NCT00000822 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

Development of a New HIV Vaccine

NCT00051922 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

NCT00001042 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

NCT00851383 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers

NCT00000832 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant

NCT00001019 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002005 ·Status: COMPLETED ·Phase: NA

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

NCT00001031 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

NCT05043129 ·Status: UNKNOWN

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

NCT00107549 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779 ·Status: COMPLETED ·Phase: PHASE1

Reactogenicity and Immunogenicity of Vaginal CNgp140

NCT00637962 ·Status: TERMINATED ·Phase: PHASE1

A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults

NCT03699241 ·Status: COMPLETED ·Phase: PHASE1

Study of Immune Responses Induced by a HIV Vaccine

NCT01933685 ·Status: UNKNOWN ·Phase: PHASE2

Study Evaluating Vaccine in Adults With HIV

NCT00195312 ·Status: TERMINATED ·Phase: PHASE1

The Safety and Immunogenicity of a Potential HIV Vaccine

NCT01966900 ·Status: COMPLETED ·Phase: PHASE1

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

NCT00849680 ·Status: COMPLETED ·Phase: PHASE1